Onusa Chantanapongwanij
Artia Global Partners Lp
Assets Managed
$499.42M
Holdings
49
Last Quarter
2026 - Q1
Filed Date
1mo 9d ago
Growth Rate
-29.23%(2Q avg: -8.68%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Artia Global Partners Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 49 positions.
Assets under management
The assets under management (AUM) of Artia Global Partners Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 499.42M in assets, with a quarterly growth rate of -29.23% and a 2-quarter average growth rate of -8.68%. The portfolio is managed by Onusa Chantanapongwanij, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
INSM Insmed Inc
| 29.75% | $148.544M 908,412 shares@ $163.52 avg price | Decreased -17.58% |
ABVX Abivax Sa-adr
| 13.4% | $66.893M 600,747 shares@ $111.35 avg price | Decreased -1.62% |
LLY Eli Lilly & Co
| 7.04% | $35.154M 38,220 shares@ $919.77 avg price | Decreased -24.31% |
TRVI Trevi Therapeutics Inc
| 4.82% | $24.022M 2.014M shares@ $11.94 avg price | |
ARGX Argenx Se - Adr
| 4.35% | $21.717M 29,739 shares@ $730.26 avg price | Decreased -54.03% |
AZNCF Astrazeneca Plc
| 3.77% | $18.81M 95,376 shares@ $197.23 avg price | New Position |
NAMS Newamsterdam Pharma Co Nv
| 3.23% | $16.131M 503,936 shares@ $32.01 avg price | |
DNTH Dianthus Therapeutics Inc
| 2.74% | $13.678M 162,990 shares@ $83.93 avg price | Decreased -20.52% |
RVMD Revolution Medicines Inc
| 2.44% | $12.155M 124,990 shares@ $97.26 avg price | Increased 19.97% |
IONS Ionis Pharmaceuticals Inc
| 2.18% | $10.841M 144,376 shares@ $75.1 avg price |
1-10 of 49